Prof. Dr. med. Georg Schett

Lehrstuhl für Innere Medizin III Einrichtungen, die zum Universitätsklinikum Erlangen gehören

Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion (2020) Simon D, Tascilar K, Krönke G, Kleyer A, Zaiss M, Heppt F, Meder C, et al. Journal article PPARδ-mediated mitochondrial rewiring of osteoblasts determines bone mass (2020) Müller D, Stoll C, Palumbo-Zerr K, Böhm C, Krishnacoumar B, Ipseiz N, Taubmann J, et al. Journal article Targeting zonulin and intestinal epithelial barrier function to prevent onset of arthritis (2020) Tajik N, Frech M, Schulz O, Schälter F, Lucas S, Azizov V, Dürholz K, et al. Journal article Ethanol consumption inhibits TFH cell responses and the development of autoimmune arthritis (2020) Azizov V, Dietel K, Steffen F, Dürholz K, Meidenbauer J, Lucas S, Frech M, et al. Journal article IgA subclasses have different effector functions associated with distinct glycosylation profiles (2020) Steffen U, Koeleman CA, Sokolova MV, Bang H, Kleyer A, Rech J, Unterweger H, et al. Journal article Massive nodulous lesions on hands and feet in a RA patient and improvement under baricitinib treatment (2020) Valor-Méndez L, Hagen M, Kleyer A, Manger B, Schett G Journal article Disentangling inflammatory from fibrotic disease activity by fibroblast activation protein imaging (2020) Schmidkonz C, Rauber S, Atzinger A, Agarwal R, Götz TI, Soare A, Cordes M, et al. Journal article Transmembrane TNF drives osteoproliferative joint inflammation reminiscent of human spondyloarthritis (2020) Kaaij MH, van Tok MN, Blijdorp IC, Ambarus CA, Stock M, Pots D, Knaup VL, et al. Journal article A Detailed Analysis of the Association between Urate Deposition and Erosions and Osteophytes in Gout (2020) Pecherstorfer C, Simon D, Unbehend S, Ellmann H, Englbrecht M, Hartmann F, Figueiredo C, et al. Journal article Secukinumab Significantly Decreased Joint Synovitis Measured by Power Doppler Ultrasonography in Biologic-naive Patients with Active Psoriatic Arthritis: Primary (12-Week) Results from a Randomized, Placebo-Controlled Phase III Study (2020) D'Agostino M, Schett G, Lopez-Rdz A, Senolt L, Maldonado-Cocco J, Burgos-Vargas R, Naredo E, et al. Conference contribution